Efficacy and safety of JMT103 in patients with giant cell tumor of bone: A multicenter, single-arm, open-label, phase Ib/II study.

Xiaohui Niu, Tao Li, Chongqi Tu et al.|Journal of Clinical Oncology|2021

Cited by 4